Appointed
Nicholas Geeza
Chief Financial Officer
Global Technology Acquisition Corp. I
(ii) Nicholas Geeza - Chief Financial Officer of the Company
Executive movement radar
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 5451–5500 of 18416
Appointed
Garry Lowenthal
Chief Financial Officer
PETV ·
PetVivo Holdings, Inc.
led by Garry Lowenthal, the Company’s new Chief Financial Officer.
Appointed
(interim)
Jeffrey Peck
Interim Chief Financial Officer
ISUN, INC.
Effective April 16, 2024, the Board appointed Jeffrey Peck to serve as Chief Executive Officer and Interim Chief Financial Officer.
Departed
Robert J. Zulkoski
Chief Executive Officer
ISUN, INC.
Effective April 16, 2024, Robert J. Zulkoski relinquished his role as Chief Executive Officer of the Company.
Appointed
Jeffrey Peck
Chief Executive Officer
ISUN, INC.
Effective April 16, 2024, the Board appointed Jeffrey Peck to serve as Chief Executive Officer and Interim Chief Financial Officer.
Departed
(interim)
Jeffrey Peck
Interim Chief Financial Officer
ISUN, INC.
Effective April 17, 2024, Mr. Peck resigned as Interim Chief Financial Officer.
Appointed
(interim)
Rob Vanderbeek
Interim Chief Financial Officer
ISUN, INC.
Effective April 17, 2024, the Board appointed Rob Vanderbeek to serve as Interim Chief Financial Officer pursuant to a Letter of Engagement between Novo Advisors, LLC and the Company, dated April 16, 2024.
Departed
Blake Lawson
Chief Financial Officer
RDNW ·
RideNow Group, Inc.
On April 18, 2024, Blake Lawson delivered a letter of resignation to RumbleOn, Inc. (the "Company") under Section 5(b) of the Executive Employment Agreement dated as of January 19, 2023, by and between Mr. Lawson and the Company. Mr. Lawson will continue to serve as Chief Financial Officer of the Company through the Company's 2024 Annual Meeting of Shareholders on June 4, 2024.
Appointed
Peter Kuipers
Chief Financial Officer
CLOV ·
CLOVER HEALTH INVESTMENTS, CORP. /DE
On April 22, 2024, Clover Health Investments, Corp. (the “Company”) announced that Peter Kuipers will become Chief Financial Officer of the Company, to serve as the Company’s principal financial officer and principal accounting officer, effective as of the day after the filing of the Company’s Quarterly Report on Form 10-Q for the quarter-ended March 31, 2024, as approved by the Board of Directors of the Company on April 16, 2024.
Departed
(interim)
Terrence Ronan
Interim Chief Financial Officer
CLOV ·
CLOVER HEALTH INVESTMENTS, CORP. /DE
Mr. Kuipers will succeed Terrence Ronan, the Company’s current Interim Chief Financial Officer, who will continue in his role as Interim Chief Financial Officer until Mr. Kuipers becomes Chief Financial Officer, and thereafter cease to serve as the Company’s principal financial officer and principal accounting officer.
Appointed
Hull Xu
Chief Financial Officer
VELO ·
Velo3D, Inc.
On April 20, 2024, the Company and Hull Xu entered into an Offer Letter (the “Offer Letter”), dated as of April 19, 2024, providing for the employment of Mr. Xu as the Company’s Chief Financial Officer and principal financial officer.
Departed
Bernard Chung
Acting Chief Financial Officer
VELO ·
Velo3D, Inc.
On April 17, 2024, Bernard Chung, Acting Chief Financial Officer of the Company, notified the Company of his intention to resign effective April 29, 2024.
Departed
Jim McCarthy
Chief Financial Officer
WHLM ·
Wilhelmina International, Inc.
On April 15, 2024, Mr. Jim McCarthy resigned from his position as the Company’s Chief Financial Officer, effective as of such date.
Appointed
Gaurav Pahwa
Chief Financial Officer
WHLM ·
Wilhelmina International, Inc.
On April 15, 2024, Wilhelmina International, Inc. (the “ Company ”) engaged Mr. Gaurav Pahwa as the Company’s Chief Financial Officer
Departed
(interim)
Carroll K. Lane
Senior Vice President and Interim Chief Financial Officer
KAMAN Corp
Mr. Lane, Senior Vice President and Interim Chief Financial Officer, and Richard S. Smith, Jr., Senior Vice President, General Counsel, and Secretary, were notified that their employment with the Company will be terminated with an effective date of no later than May 31, 2024, in the case of Mr. Smith, and no later than June 30, 2024, in the case of Mr. Lane, in each case unless an earlier termination date is mutually agreed between each executive officer and the Company.
Departed
Tham Choi Kuen
Chief Financial Officer
GTIJF ·
GRAPHJET TECHNOLOGY
received a notice from Tham Choi Kuen (“Ms. Kuen”), who served as the Chief Financial Officer (the “CFO”) of the Company, of her decision to resign as the CFO of the Company due to health reasons effective immediately.
Role change
(interim)
Aiden Lee Ping Wei
Interim Chief Financial Officer (and principal financial and accounting officer)
GTIJF ·
GRAPHJET TECHNOLOGY
the Board determined that upon Ms. Kuen’ resignation on April 18, 2024, Aiden Lee Ping Wei (“Mr. Aiden Lee”), the Company’s current Chief Executive Officer and director, will serve as the Company’s interim CFO and will assume the roles of principal financial officer and principal accounting officer.
Appointed
Hai Shi
Co-Chief Executive Officer
SNAL ·
Snail, Inc.
On April 15, 2024, in conjunction with Mr. Tsai’s resignation as the Company’s Chief Executive Officer, the Company appointed Hai Shi and Xuedong (Tony) Tian to serve as the Company’s new Co-Chief Executive Officers, effective April 15, 2024.
Departed
Jim S. Tsai
Chief Executive Officer
SNAL ·
Snail, Inc.
On April 15, 2024, Jim S. Tsai notified Hai Shi, the Chairman of the Board of Directors (the “Board”) and Chief Strategy Officer of Snail, Inc. (the “Snail”), of his decision to resign from his position as the Chief Executive Officer of Snail
Appointed
Xuedong (Tony) Tian
Co-Chief Executive Officer
SNAL ·
Snail, Inc.
On April 15, 2024, in conjunction with Mr. Tsai’s resignation as the Company’s Chief Executive Officer, the Company appointed Hai Shi and Xuedong (Tony) Tian to serve as the Company’s new Co-Chief Executive Officers, effective April 15, 2024.
Departed
Juan Fernandez Pascual
Chief Executive Officer, Secretary and director
AFJK ·
Aimei Health Technology Co., Ltd.
On April 15, 2024, Juan Fernandez Pascual tendered to the board of directors of Aimei Health Technology Co., Ltd. (the “ Company ”) his resignation, effective as of that date, as Chief Executive Officer, Secretary and a director of the Company.
Appointed
Junheng Xie
Chief Executive Officer, Secretary and director
AFJK ·
Aimei Health Technology Co., Ltd.
On April 19, 2024, the board of directors of the Company appointed Mr. Junheng Xie as the Chief Executive Officer, Secretary and a director of the Company with effect from April 15, 2024.
Departed
(interim)
Michael J. McDermott
Chief Financial Officer
RBKB ·
Rhinebeck Bancorp, Inc.
On January 31, 2024, Rhinebeck Bancorp, Inc. (the “Company”), the holding company of Rhinebeck Bank, announced the retirement of Michael J. McDermott, Chief Financial Officer of the Company.
Appointed
(interim)
Phillip Lekanides
Interim Principal Financial and Accounting Officer
RBKB ·
Rhinebeck Bancorp, Inc.
The current Vice President and Controller of the Company, Phillip Lekanides, has been named Interim Principal Financial and Accounting Officer effective June 1, 2024, and will manage the responsibilities of the principal financial and accounting officer in addition to his current responsibilities until a permanent replacement is named.
Appointed
Michael Beer
Chief Financial Officer
NRGV ·
Energy Vault Holdings, Inc.
reporting that Johannes Cornelis Maria van Gaalen will cease to serve as Chief Financial Officer concurrently with Michael Beer assuming the position of Chief Financial Officer on April 15, 2024.
Departed
Johannes Cornelis Maria van Gaalen
Chief Financial Officer
NRGV ·
Energy Vault Holdings, Inc.
reporting that Johannes Cornelis Maria van Gaalen will cease to serve as Chief Financial Officer concurrently with Michael Beer assuming the position of Chief Financial Officer on April 15, 2024.
Appointed
Gustavo Garavaglia
Vice President and Chief Financial Officer of IPALCO and AES Indiana
IPALCO ENTERPRISES, INC.
appointed Gustavo Garavaglia as Vice President and Chief Financial Officer of IPALCO and AES Indiana and to the Board of Directors of AES Indiana.
Appointed
Eric Esser
President and Chief Executive Officer
Telesis Bio Inc.
Eric Esser, who had been serving as the Company's President and Chief Operating Officer, assumed the position of President and CEO for the Company, effective as of April 16, 2024
Role change
Todd R. Nelson
Chief Executive Officer
Telesis Bio Inc.
Todd R. Nelson, Ph.D., Founder, Chief Executive Officer (CEO) of the Company and member of the Company’s Board of Directors (the Board), will cease serving as the Company's CEO, effective as of April 16, 2024, and will remain a member of the Board
Departed
Steven Norman
Chief Financial Officer, Director, and President
TLGYF ·
TLGY ACQUISITION CORP
on March 28, 2024, the Company received a notice from Steven Norman (“Mr. Norman”), who served as a director and the Chief Financial Officer (the “CFO”) of the Company, of his decision to resign as the CFO of the Company and as a member of the Board and all committees thereof, effective on March 28, 2024.
Appointed
Pravin U. Dugel, M.D.
President and Chief Executive Officer
OCUL ·
OCULAR THERAPEUTIX, INC
On April 14, 2024 (the “Transition Date”), the board of directors of Ocular Therapeutix, Inc. (the “Company”) appointed Pravin U. Dugel, M.D., to serve as President and Chief Executive Officer of the Company.
Departed
Antony C. Mattessich
President and Chief Executive Officer
OCUL ·
OCULAR THERAPEUTIX, INC
On the Transition Date, Dr. Dugel succeeded Antony C. Mattessich as the Company’s President and Chief Executive Officer, and Mr. Mattessich resigned from the board of directors of the Company.
Appointed
Michael Yung
Chief Financial Officer
PEVM ·
PHOENIX MOTOR INC.
On April 17, 2024, Phoenix Motor Inc. (the “Company”) appointed Michael Yung as the Company’s Chief Financial Officer, effective immediately.
Appointed
(interim)
Jacqueline Hernández
Interim Chief Executive Officer
MDIA ·
Mediaco Holding Inc.
In connection with the Transactions, effective as of the Closing Date, Jacqueline Hernández, age 58, was appointed as MediaCo’s Interim Chief Executive Officer.
Departed
Sung Lee
Executive Vice President and Chief Financial Officer
VIR ·
Vir Biotechnology, Inc.
On April 15, 2024, Sung Lee, Executive Vice President and Chief Financial Officer of Vir Biotechnology, Inc. (the “Company”), informed the Company that he will be stepping down from his role, effective May 3, 2024, to pursue another career opportunity.
Appointed
Craig Gifford
Senior Executive Vice President and Chief Financial Officer
FLG ·
FLAGSTAR BANK, NATIONAL ASSOCIATION
On April 12, 2024, New York Community Bancorp, Inc. (“NYCB” or the “Company”) announced that Craig Gifford was appointed as Senior Executive Vice President and Chief Financial Officer of the Company and Flagstar Bank, N.A., a wholly owned subsidiary of the Company (the “ Bank ”), effective immediately.
Departed
John J. Pinto
Senior Executive Vice President and Chief Financial Officer
FLG ·
FLAGSTAR BANK, NATIONAL ASSOCIATION
Mr. Gifford succeeds John J. Pinto, who ceased serving as Senior Executive Vice President and Chief Financial Officer of the Company and the Bank on April 12, 2024.
Appointed
Scott Shepherd
Senior Executive Vice President and Head of Commercial Real Estate
FLG ·
FLAGSTAR BANK, NATIONAL ASSOCIATION
On April 12, 2024, the Company announced that Scott Shepherd was appointed as Senior Executive Vice President and Head of Commercial Real Estate of the Company and the Bank, effective immediately.
Role change
Kenneth S. Wilson
Chief Executive Officer and Director
JBL ·
JABIL INC
On April 15, 2024, Mr. Kenneth S. Wilson, Chief Executive Officer and Director of Jabil Inc. (the “Company”), was placed on a paid leave pending completion of an investigation related to corporate policies.
Appointed
(interim)
Michael Dastoor
interim Chief Executive Officer
JBL ·
JABIL INC
Effective as of April 19, 2024, the Company’s Board of Directors appointed Mr. Michael Dastoor, Chief Financial Officer, to serve as the Company’s interim Chief Executive Officer.
Appointed
Stephen Zsigray
President and Chief Executive Officer
AHT ·
ASHFORD HOSPITALITY TRUST INC
the Board of Directors of the Company appointed Ashford’s current Senior Vice President of Corporate Finance & Strategy, Stephen Zsigray, to fill the role of President and Chief Executive Officer at the Company, effective June 30, 2024.
Departed
J. Robison Hays, III
President and Chief Executive Officer
AHT ·
ASHFORD HOSPITALITY TRUST INC
Mr. Hay’s resignation is expected to be effective June 30, 2024.
Appointed
Raymond Stachowiak
Chief Executive Officer
AMS ·
AMERICAN SHARED HOSPITAL SERVICES
Raymond Stachowiak, who has served as the Executive Chairman of the Board since March 7, 2023, was appointed as Chief Executive Officer in addition to continuing to serve as the Company’s Executive Chairman of the Board.
Departed
Peter Gaccione
Chief Executive Officer
AMS ·
AMERICAN SHARED HOSPITAL SERVICES
After the recent passing of Peter Gaccione, who served as the Chief Executive Officer of American Shared Hospital Services (the “ Company ”), on April 16, 2024,
Departed
(interim)
Grant Begley
Interim Chief Executive Officer
UAVS ·
AgEagle Aerial Systems Inc.
Effective as of April 15, 2024, Mr. Grant Begley ceased to serve as the Interim Chief Executive Officer of the Company
Appointed
Bill Irby
Chief Executive Officer
UAVS ·
AgEagle Aerial Systems Inc.
setting forth the terms of Bill Irby’s appointment as Chief Executive Officer and Director of the Company effective as of April 15, 2024.
Appointed
Jeremy Davey
Chairman of the Board of Directors and Chief Executive Officer
SYBLEU Inc
immediately following the Effective Time, the officers of the Company became: (i) Jeremy Davey as Chairman of the Board of Directors and Chief Executive Officer
Appointed
David Edmunds
Chief Financial Officer
YQAI ·
YOUNEEQAI TECHNICAL SERVICES, INC.
On April 15, 2024, the Board of Directors (“Board”) appointed David Edmunds as Chief Financial Officer, effective immediately (the “Effective Date”).
Departed
Stacy Lindborg
Co-Chief Executive Officer
BCLI ·
BRAINSTORM CELL THERAPEUTICS INC.
Dr. Stacy Lindborg, the Co-Chief Executive Officer of Brainstorm Cell Therapeutics Inc. (the “Company”), provided the Company with notice of her intent to resign from her current role at the Company, effective as of May 9, 2024.
Appointed
Suzanne Foster
Chief Executive Officer
AHCO ·
AdaptHealth Corp.
Suzanne Foster, age 54, has been appointed to serve as the Chief Executive Officer of the Company, effective May 20, 2024.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.